Xbrane Biopharma
76,6 SEK +0,13 %1 investor følger denne virksomhed
Xbrane Biopharma is a biotechnology company. The company specializes in research and development of drugs for the treatment of critical illnesses. Today, the business is focused on research in microspherical technology and in the development of protein molecules. The products are used in the treatment of prostate cancer and endometriosis, as well as in rare and serious eye diseases. The company's head office is located in Solna.
Omsætning
57,62 mio.
EBIT %
-288,48 %
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
NASDAQ Stockholm
XBRANE
Daglig lav / høj pris
76,2 / 77,6
SEK
Markedsværdi
2,24 mia. SEK
Aktieomsætning
3,04 mio. SEK
Volumen
39 t
Seneste videoer
Finanskalender
Delårsrapport
31.08.2023
Viser Alle indholdstyper
